Paclitaxel: all 2,138 studies that test it
Page 19 of 22. Open to participants first (342), then studies with results posted, then the rest; newest registration first within each.
- Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate CancerCompletedNCT00284752Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00281788Phase 1
- Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimCompletedNCT00280787Phase 2
- Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgerySuspendedNCT00278122Phase 2
- A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With TaxanesCompletedNCT00277043Phase 3
- Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00276796Phase 2
- Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00276588Phase 2
- An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With CarboplatinCompletedNCT00274443Phase 2
- Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3TerminatedNCT00273507Phase 3
- Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.CompletedNCT00270491Phase 2
- A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.TerminatedNCT00269828Phase 3
- Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLCCompletedNCT00259675Phase 2
- Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00255762Phase 2
- Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00254891Phase 3
- Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast CancerTerminatedNCT00251095Phase 3
- Combination Paclitaxel, Carboplatin and TemozolomideCompletedNCT00249964Phase 1
- High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF IICompletedNCT00231582Phase 2
- Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian CarcinomaCompletedNCT00226915Phase 3
- Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic CancerWithdrawnNCT00226746Phase 2
- Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryCompletedNCT00217607Phase 2
- Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.WithdrawnNCT00209612Phase 1/2
- Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of EsophagusTerminatedNCT00208936Phase 2
- Chemoradiotherapy of NSCLC Stage IIIBCompletedNCT00198432Phase 2
- Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine CarcinomaCompletedNCT00193531Phase 2
- Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung CancerCompletedNCT00193362Phase 3
- Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal CarcinomaCompletedNCT00193297Phase 2
- Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate CarcinomaCompletedNCT00193193Phase 2
- Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal CancerCompletedNCT00193141Phase 2
- A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCompletedNCT00191672Phase 2
- Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung CancerCompletedNCT00191256Phase 2
- Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early RelapseCompletedNCT00189566Phase 2
- Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or PeritoneumTerminatedNCT00189371Phase 3
- Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian OriginCompletedNCT00181701Phase 2
- Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck CancerCompletedNCT00176267Phase 2
- Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck CancerTerminatedNCT00176241Phase 1
- Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast CancerCompletedNCT00174434Phase 1
- PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC PatientsCompletedNCT00174356Phase 1
- Study for Patients With Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00168883Phase 2
- Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast CancerStatus unknownNCT00154882Phase 2
- Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric CancerCompletedNCT00154778Phase 2
- Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal CancerCompletedNCT00154700Phase 2
- Weekly TP-HDFL in the Treatment of Advanced TCCCompletedNCT00154687Phase 2
- Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the ProstateCompletedNCT00151060Phase 2
- Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerCompletedNCT00151034Phase 2
- Uterine Papillary Serous Cancer (UPSC) TrialCompletedNCT00147680Phase 2
- Selective Dose Escalation for Esophageal CancerStatus unknownNCT00139633Phase 2
- Neoadjuvant Therapy With Herceptin and Taxol for Breast CancerCompletedNCT00136539Phase 2
- Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the BladderCompletedNCT00136175Phase 2
- Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast CancerCompletedNCT00129922Phase 3
- Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00128856Phase 2
- Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid TumorsCompletedNCT00113438Phase 2
- Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast CancerCompletedNCT00111787Phase 2
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00107341Phase 2
- Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast CancerCompletedNCT00107094Phase 1
- Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced CancerCompletedNCT00100139Phase 1
- Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097227Phase 2
- Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast CancerCompletedNCT00096668Phase 2
- Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast CancerCompletedNCT00096343Phase 2
- Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00095914Phase 1
- Trial of ABI-007 in Previously Treated Patients With Metastatic MelanomaCompletedNCT00093119Phase 2
- Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00091377Phase 1/2
- Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00088556Phase 1/2
- STA-4783 and Paclitaxel for Treatment of Solid TumorsCompletedNCT00088114Phase 1
- STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)CompletedNCT00088088Phase 1/2
- 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid TumorCompletedNCT00087217Phase 1
- S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00085501Phase 2
- Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)CompletedNCT00085358Phase 1
- Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate CancerWithdrawnNCT00084565Phase 2
- Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerTerminatedNCT00084448Phase 2
- STA-4783/Paclitaxel or Paclitaxel Alone in MelanomaCompletedNCT00084214Phase 1/2
- Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00083057Phase 1
- Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00081302Phase 2
- ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic MelanomaCompletedNCT00081042Phase 2
- Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00079430Phase 1
- Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00079287Phase 3
- TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the UrotheliumCompletedNCT00077688Phase 2
- ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung CancerCompletedNCT00077246Phase 1/2
- Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung CancerStatus unknownNCT00077220Phase 3
- Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell CancerCompletedNCT00077129Phase 2
- Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073723Phase 1/2
- Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00072319Phase 2
- Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell TumorsTerminatedNCT00072215Phase 3
- ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT00071188Phase 2
- Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast CancerStatus unknownNCT00070278Phase 3
- Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast CancerCompletedNCT00068757Phase 1
- Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the EsophagusCompletedNCT00066716Phase 2
- Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube CancerCompletedNCT00063401Phase 2
- Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung CancerCompletedNCT00062062Phase 2
- S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical CancerWithdrawnNCT00057928Phase 3
- S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumCompletedNCT00055835Phase 2
- Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid TumorsCompletedNCT00054548Phase 1
- Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWithdrawnNCT00054392Phase 3
- Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054210Phase 3
- Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial CancerCompletedNCT00052312Phase 2
- Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung CancerCompletedNCT00049790Phase 2
- Study of ABI-007 and Taxol in Patients With Metastatic Breast CancerCompletedNCT00046527Phase 3
- ABI-007 in Taxol Resistant Patients With Metastatic Breast CancerCompletedNCT00046514Phase 2
- A Trial of ABI-007 in Patients With Advanced Non-Hematologic MalignanciesCompletedNCT00046423Phase 1
- Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00042809Phase 1
- A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00042302Phase 3